primary liver cancer
Conditions
Interventions
Sponsors
Shuguang Hospial Affiliated to Shanghai University of TCM
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. patients with primary liver cancer after radical resection (BCLC stage B, stage C); 2. aged 18 to 70 years; 3. The patients had not received systematic treatment before, including molecular targeted drug therapy, systemic chemotherapy, immunotherapy, etc; 4. Patients who are unable or unwilling to accept surgery or have disease progression after local treatment and cannot be operated again; 5. willing to accept Chinese medicine and/or integrated Chinese and western medicine treatment; 6. sign informed consent.
Exclusion criteria
Exclusion criteria: 1. metastatic liver cancer patients, or concurrent with other cancer patients; 2. Patients with refractory ascites, hepatic encephalopathy, hepatorenal syndrome and other serious complications; 3. accompanied by heart, kidney, lung, endocrine, blood, metabolism and gastrointestinal tract serious primary disease; Or mentally ill; 4. legally disabled persons, pregnant women or nursing women; 5. allergy or multiple drug allergy patients; 6. Currently participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 year Survival period; | — |
Secondary
| Measure | Time frame |
|---|---|
| objective response rate;PIVKA-II;Child-pugh grading;Abdominal ultrasound;disease control rate;liver function;MRI;AFP;Quality of Life Scale; | — |
Countries
China
Contacts
Public ContactXuehua Sun
Shuguang Hospital affiliated to Shanghai Universtiy of Traditonal Chinese Medicine
Outcome results
None listed